Cellebration Life Sciences, Inc. announced it raised $1.29 Million in an amended filing from an offering of $20 Million

Jun 13, 2022•over 3 years ago

Amount Raised

$1.29 Million

Round Type

seed

PhoenixBiotechnology

Company Information

Company

Cellebration Life Sciences, Inc.

Location

12601 N. CAVE CREEK ROAD, SUITE 111

Phoenix, Arizona, United States

About

Cellebration Life Sciences is a pre-clinical trial R&D company focused on a permanent curative treatment for Type 2 Diabetes through the use of Stem Cells.

Cellebration Life Sciences, Inc. announced it raised $1.29 Million in an amended filing from an offering of $20 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information